In vitro assessment of the efficiency of the PIM‑1 kinase pharmacological inhibitor as a potential treatment for Burkitt's lymphoma-Reference-Cited by-同舟云学术

In vitro assessment of the efficiency of the PIM‑1 kinase pharmacological inhibitor as a potential treatment for Burkitt's lymphoma

Published:2021-06-29 Issue:2 Volume:22 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Alsubaie Mona¹,Matou‑nasri Sabine¹,Aljedai Abdullah²,Alaskar Ahmed ³,Al‑Eidi Hamad¹,Albabtain Sarah⁴,Aldilaijan Khawlah ⁴,Alsayegh Manal¹,Alabdulkareem Ibrahim¹

Affiliation:

1. Cell and Gene Therapy Group, Medical Genomics Research Department, King Abdullah International Medical Research Center, Ministry of National Guard‑Health Affairs, Riyadh 11481, Saudi Arabia

2. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia

3. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia

4. Research Department, Health Sciences Research Center, Princess Nourah Bint Abdulrahman University, Riyadh 11564, Saudi Arabia

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target;International Journal of Biological Macromolecules;2024-06

2. Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma;World Journal of Surgical Oncology;2023-03-04

3. Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition;Cancers;2023-02-07